west china medical publishers
Author
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Author "陈世雄" 6 results
  • Clinical DiagnosticValue of Soluble Triggering Receptor Expressed on Myeloid Cells-1 in Ventilator- Associated Pneumonia

    Objective To evaluate the diagnostic value of soluble triggering receptor expressed on myeloid cells-1 ( sTREM-1 ) in endotracheal aspirate and plasma of patients with ventilator-associated pneumonia ( VAP) . Methods The consentration of sTREM-1 in plasma and endotracheal aspirate, and serum high-sensitivity C-reactive protein ( hs-CRP) were measured by enzyme-linked immunosorbent assay ( ELISA) in 68 patients with VAP ( VAP group) , 50 patients underwent ventilation without VAP ( non-VAP group) , and 50 healthy individuals ( control group) . The sensitivity and specificity of each parameter were calculated. Results In the patients with VAP, sTREM-1 in plasma and endotracheal aspirate before treatment were significantly higher than that in the non-VAP group [ ( 143.62 ±46.82) pg/mL vs. ( 68.56 ±16.24) pg/mL, ( 352.86 ±92.57) pg/mL vs. ( 126.21 ±42.28) pg/mL, Plt;0.05] ; sTREM-1 in plasma and endotracheal aspirate on the 3rd and the 7th day during treatment were significantly decreased ( Plt;0. 05) . By ROC analysis, the cut-off value of sTREM-1 in endotracheal aspirate were 193.64 pg/mL, with sensitivity and specificity of 93.84% and 89.51% respectively. The areas under ROC curve of sTREM-1 in endotracheal aspirate were 0.912. Clinical diagnostic value of sTREM-1 in endotracheal aspirate was better than plasma sTREM-1 and serum hs-CRP ( areas under ROC curve were 0. 768 and 0. 704 respectively) . Conclusions sTREM-1 may be helpful for evaluating the therapeutic effect in patients with VAP. The diagnostic value of sTREM-1 in endotracheal aspirate may be superior to plasma sTREM-1 and serum hs-CRP.

    Release date:2016-09-13 04:00 Export PDF Favorites Scan
  • 全肺灌洗治疗吸入性肺炎一例

    Release date:2016-09-13 04:00 Export PDF Favorites Scan
  • 支气管镜联合胸腔镜手术治疗大咯血32例临床体会

    目的探讨支气管镜联合胸腔镜手术治疗大咯血的可行性、安全性和有效性。 方法回顾性分析九江市第一人民医院胸外科自2009年5月至2013年4月完成的32例经支气管镜联合胸腔镜手术治疗大咯血患者的临床资料。其中男19例、女13例,年龄24~60(40.2±9.1)岁;因支气管扩张致大咯血24例,肺癌合并咯血6例,肺结核咯血2例。 结果2例(6%)因胸腔粘连严重而中转开胸。1例因气管内出血量大,纤维支气管镜无法准确定位,终止手术,最终死亡。余29例在全胸腔镜下完成肺叶切除术,包括右肺上叶切除4例,右肺下叶12例,左肺下叶10例,左肺上叶3例。其中6例术中冰冻病理检查提示癌,加做淋巴结清扫术;1例右肺上叶支气管扩张行右肺上叶切除术后第3 d再次出现大咯血,手术证实为右肺中叶再次出血,行右肺中叶切除术;其余22例术后均无咯血。 结论支气管镜联合胸腔镜手术治疗大咯血是一种安全有效的方法。

    Release date: Export PDF Favorites Scan
  • Single Port Thoracoscopy Surgery in Treatment of Anterior Mediastinal Tumor

    目的探讨单操作孔胸腔镜在纵隔肿瘤治疗中的临床应用价值。 方法回顾性分析我科2012年至3月至2014年3月我院胸外科采用单操作孔胸腔镜切除纵隔肿瘤18例的临床资料,男11例、女7例,年龄45.5(30~55)岁。胸腺瘤12例,胸腺瘤合并重症肌无力3例,胸腺囊肿4例,畸胎瘤2例。 结果所有患者均在胸腔镜下或胸腔镜辅助下完成,其中16例采用单操作孔胸腔镜下操作,其中有1例因术中出血,延长操作孔切口,完成止血,另有1例因肿瘤直径约8 cm,合并胸膜腔部分粘连,增加一副操作孔完成。术中操作时间80(40~120)min,术中出血量100(50~300)ml,术后胸腔引流管留置时间3(2~5)d,住院时间6(4~8)d,均未出现严重并发症。术后随访18例患者1个月至2年,均未见肿瘤复发,其中合并重症肌无力的3例患者,术后肌无力均消失。 结论单操作孔胸腔镜治疗前纵隔肿瘤是安全有效且可行的。

    Release date: Export PDF Favorites Scan
  • Advances in nanostructured surfaces for enhanced mechano-bactericidal applications

    The issue of bacterial drug resistance has remained unresolved, and in recent years, biomimetic nanostructured surfaces inspired by nature have garnered significant attention due to their bactericidal properties demonstrated through mechanical mechanisms. This article reviewed the main research progress in the field of nanostructured mechanical bactericidal surfaces, including various preparation methods for nanostructured surfaces with mechanical bactericidal properties, as well as the basic mechanisms and related physical models of the interaction between bacteria and nanostructured surfaces. In addition, the application of nanostructured surfaces in biomedicine was introduced. Finally, the article proposed the major challenges faced by mechanical bactericidal research and the future development direction.

    Release date: Export PDF Favorites Scan
  • 吉非替尼致间质性肺疾病二例并文献复习

    目的 提高对吉非替尼所致间质性肺疾病诊断和治疗的认识。方法 对2 例吉非替尼所致间质性肺疾病予以报道, 结合有关文献进行回顾性分析。结果 间质性肺疾病是吉非替尼较严重的不良反应, 其所致肺损伤的危险因素包括高龄、吸烟史、PS gt;2、应用时已存在肺间质性疾病或肺部感染、曾用化疗或放疗者; 临床上早期多表现为发热、干咳和呼吸困难, 肺CT 多提示以双肺弥漫性毛玻璃样浸润影和肺实变为主; 大多在应用1 个月内发生, 进展迅速; 治疗上以激素为主, 辅以抗感染和无创呼吸支持治疗, 可在短时间内控制病情。结论 吉非替尼所致间质性肺疾病是临床上严重的不良反应, 激素治疗辅以无创呼吸支持可有效缓解病情。

    Release date:2016-09-13 03:54 Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content